XML 57 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration Agreements - Schedule of Significant Changes in Deferred Revenue Balances, Teva Collaboration (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Disaggregation of Revenue [Line Items]    
Increase as a result of cumulative-effect adjustment arising from the adoption of ASC 606 $ (29,462) $ (59,116)
Teva | Accounting Standards Update 2014-09    
Disaggregation of Revenue [Line Items]    
Increase as a result of cumulative-effect adjustment arising from the adoption of ASC 606 48,216  
Increase due to amounts invoiced, excluding amounts recognized as revenue during the period 33,774  
Revenue recognized that was included in deferred revenue at the beginning of the period $ (67,771)